Ballentine Partners, LLC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 246 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.

Quarter-by-quarter ownership
Ballentine Partners, LLC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$304,241
-22.8%
1,403
-35.4%
0.01%
-30.0%
Q1 2023$394,340
+22.1%
2,171
+32.1%
0.01%0.0%
Q4 2022$322,850
+23.7%
1,643
+41.6%
0.01%
+11.1%
Q3 2022$261,0001,1600.01%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 797,008$134,766,08353.75%
Nan Fung Group Holdings Ltd 225,688$38,161,58430.90%
Sofinnova Investments, Inc. 1,381,149$233,538,48414.73%
First Light Asset Management, LLC 303,137$51,257,4354.87%
Altium Capital Management LP 34,000$5,749,0603.00%
DAFNA Capital Management LLC 52,873$8,940,2962.78%
Logos Global Management LP 115,000$19,445,3502.59%
GENERAL ATLANTIC, L.P. 986,710$166,842,7942.58%
MPM BioImpact LLC 53,210$8,997,2792.40%
Rock Springs Capital Management LP 505,433$85,463,6662.29%
View complete list of KARUNA THERAPEUTICS INC shareholders